These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21922751)

  • 1. [Vaccine adjuvant].
    Aoshi T; Ishii KJ
    Nihon Rinsho; 2011 Sep; 69(9):1547-53. PubMed ID: 21922751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From tolerance to autoimmunity: is there a risk in early life vaccination?
    Goriely S; Goldman M
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S57-61. PubMed ID: 17548092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
    Lang R; Schoenen H; Desel C
    Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants and autoimmunity.
    Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity and vaccine.
    Seya T
    Vaccine; 2010 Nov; 28(50):8041-2. PubMed ID: 20849873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant activity of cytokines.
    Tovey MG; Lallemand C
    Methods Mol Biol; 2010; 626():287-309. PubMed ID: 20099135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines.
    Qin H; Cha SC; Neelapu SS; Liu C; Wang YH; Wei J; Qin XF; Liu YJ; Kwak LW
    Vaccine; 2010 Nov; 28(50):7970-8. PubMed ID: 20937320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel adjuvants for B cell immune responses.
    Loré K; Karlsson Hedestam GB
    Curr Opin HIV AIDS; 2009 Sep; 4(5):441-6. PubMed ID: 20048709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity.
    Kindrachuk J; Jenssen H; Elliott M; Townsend R; Nijnik A; Lee SF; Gerdts V; Babiuk LA; Halperin SA; Hancock RE
    Vaccine; 2009 Jul; 27(34):4662-71. PubMed ID: 19539585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative evaluation of adjuvant activities and its application to Th2/17 diseases.
    Matsushita S; Takagi R; Hashimoto K; Higashi T
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():2-5. PubMed ID: 21646788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and direction of immune responses by vaccine adjuvants.
    Schijns VE
    Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.